Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

The NIH Common Fund, in collaboration with other NIH Institutes and Centers, plans to issue a Notice of Funding Opportunity for the Gabriella Miller Kids First Pediatric Research Program, aimed at advancing research into childhood cancer and congenital anomalies. The program focuses on uncovering genetic connections and biological mechanisms underlying these conditions to promote the development of targeted therapies and interventions. The upcoming funding opportunity will support the Genome Sequencing Center initiative, which seeks to enhance the existing data resource by incorporating new data types as technologies evolve and including clinic-based data sources. Although applications are not currently being accepted, this announcement serves to give researchers ample time to establish collaborations and prepare strong proposals. This funding opportunity will utilize the U24 activity code and specifically excludes clinical trials. Researchers with expertise in childhood cancer and congenital abnormalities are encouraged to consider applying once the opportunity becomes available. The program is managed by the National Institutes of Health under the Department of Health and Human Services, with Concepcion R. Nierras, Ph.D., serving as the primary point of contact. The initiative emphasizes the importance of expanding research infrastructure and data sharing to accelerate scientific discovery and improve outcomes for pediatric patients and families affected by these serious conditions.